James Yang

James Yang

Fish & Richardson

Contact
View Bio
RSS

Latest Publications

Share:

Federal Circuit Panel Holds Hatch-Waxman Venue Under the Second Prong of § 1400(b) is Based on Actions Related to ANDA Submission

Valeant Pharmaceuticals North America LLC v. Mylan Pharmaceuticals Inc. Last Thursday, a Federal Circuit panel issued a decision applying a narrow reading of the patent venue statute, 28 U.S.C. § 1400(b), in a Hatch-Waxman...more

11/16/2020  /  Abbreviated New Drug Application (ANDA) , Generic Drugs , Hatch-Waxman , Mylan Pharmaceuticals , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Valeant
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide